Merck’s Solid Quarter Doesn’t Soothe Seagen M&A Watchers

No Deal Was Announced, To The Chagrin Of Investors

"No Deal" sign
CEO Robert Davis declined to speculate on future transactions • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business